QTTB
Q32 Bio Inc.$11.08+0.17 (+1.56%)Prev Close$10.91·MCap$330.4M·P/E2.41·Vol465.7K·Yield—
▲
Buys (12M)
2
$30.00M
▼
Sells (12M)
6
$350.6K
◆
Net Activity
Net Buyer
$29.65M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Q32 Bio Inc. (QTTB) has been dominated by buying, with 2 insider purchases totaling $30.00M and 6 insider sales totaling $350.6K. The most recent insider transaction was by Morrison Jodie Pope (director, officer: CEO), who sold $163.0K worth of shares on Aug 27, 2026. Q32 Bio Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $330.4M.
QTTB Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Morrison Jodie Pope | director, officer: CEO | Sell | 9,845 | $16.56 | $163.0K | 343,259 |
| Aug 27, 2026 | Violette Shelia M. | officer: Chief Scientific Officer | Sell | 2,798 | $16.56 | $46.3K | 127,771 |
| Aug 27, 2026 | Kalowski Lee | officer: CFO and President | Sell | 3,972 | $16.56 | $65.8K | 138,471 |
| Jun 1, 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner: | Buy | 1,875,000 | $8.00 | $15.00M14.7% OS | 3,502,987+115% |
| Jun 1, 2026 | Xu Diyong | director, 10 percent owner: | Buy | 1,875,000 | $8.00 | $15.00M14.7% OS | 3,502,987+115% |
| Feb 27, 2026 | Kalowski Lee | officer: CFO and President | Sell | 3,995 | $4.51 | $18.0K | 35,943 |
| Feb 27, 2026 | Morrison Jodie Pope | director, officer: CEO | Sell | 9,896 | $4.51 | $44.7K | 89,104 |
| Feb 27, 2026 | Violette Shelia M. | officer: Chief Scientific Officer | Sell | 2,815 | $4.51 | $12.7K | 55,569 |
| Aug 26, 2025 | Violette Shelia M. | Chief Scientific Officer | Sell | 2,990 | $1.80 | $5.4K | 0 |
| Aug 14, 2024 | TZIANABOS ARTHUR | Sell | 265 | $24.20 | $6.4K | 7,983 | |
| Apr 23, 2024 | Alloway Paul | See Remarks | Sell | 268 | $24.21 | $6.5K | 2,596 |
| Apr 23, 2024 | Michaud Charles Jr | See Remarks | Sell | 75 | $24.20 | $1.8K | 927 |
| Feb 15, 2024 | TZIANABOS ARTHUR | Sell | 13,037 | $0.57 | $7.4K | 128,778 | |
| Jan 5, 2024 | Alloway Paul | See Remarks | Sell | 7,280 | $0.57 | $4.1K | 28,036 |
| Jan 5, 2024 | Michaud Charles Jr | See Remarks | Sell | 1,708 | $0.57 | $975.27 | 11,598 |
| Sep 8, 2023 | Seymour Albert | See Remarks | Sell | 1,448 | $1.15 | $1.7K | 150,874 |
| Aug 7, 2023 | Jordan Julie | Chief Medical Officer | Sell | 1,853 | $1.39 | $2.6K | 7,496 |
| Aug 4, 2023 | Jordan Julie | Chief Medical Officer | Sell | 99 | $1.31 | $129.69 | 2,770 |
| Mar 6, 2023 | Alloway Paul | See Remarks | Sell | 10,965 | $1.45 | $15.9K | 16,706-40% |
| Jan 11, 2023 | Alloway Paul | See Remarks | Sell | 3,090 | $1.39 | $4.3K | 20,103 |
| Jan 11, 2023 | Blum Michael Lee | Chief Commercial Officer | Sell | 2,454 | $1.39 | $3.4K | 13,538 |
| Jan 11, 2023 | Seymour Albert | See Remarks | Sell | 3,620 | $1.39 | $5.0K | 143,166 |
| Jan 11, 2023 | Smith W Bradford | See Remarks | Sell | 3,729 | $1.39 | $5.2K | 14,219 |
| Jan 11, 2023 | TZIANABOS ARTHUR | Director | Sell | 10,616 | $1.39 | $14.8K | 108,395 |
| Jan 12, 2022 | Cohn Gabriel | Chief Medical Officer | Sell | 1,661 | $3.78 | $6.3K | 2,629-39% |
| Jan 12, 2022 | Kelly Timothy P | Chief Operating Officer | Sell | 1,406 | $3.78 | $5.3K | 2,224-39% |
| Jan 12, 2022 | Seymour Albert | Chief Scientific Officer | Sell | 1,661 | $3.78 | $6.3K | 131,646 |
| Jan 12, 2022 | Smith W Bradford | CFO & Treasurer | Sell | 2,182 | $3.78 | $8.2K | 4,418-33% |
| Jan 12, 2022 | TZIANABOS ARTHUR | President & CEO | Sell | 5,354 | $3.78 | $20.2K | 86,011 |
| Sep 8, 2021 | Kelly Timothy P | See Remarks. | Sell | 54 | $7.70 | $415.80 | 0Exit |
| Mar 3, 2021 | Kelly Timothy P | See Remarks. | Sell | 6,232 | $11.16 | $69.6K | 0Exit |
QTTB Insider Buying Activity
The following table shows recent insider purchases of Q32 Bio Inc. (QTTB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner: | Buy | 1,875,000 | $8.00 | $15.00M14.7% OS | 3,502,987+115% |
| Jun 1, 2026 | Xu Diyong | director, 10 percent owner: | Buy | 1,875,000 | $8.00 | $15.00M14.7% OS | 3,502,987+115% |
QTTB Insider Selling Activity
The following table shows recent insider sales of Q32 Bio Inc. (QTTB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Morrison Jodie Pope | director, officer: CEO | Sell | 9,845 | $16.56 | $163.0K | 343,259 |
| Aug 27, 2026 | Violette Shelia M. | officer: Chief Scientific Officer | Sell | 2,798 | $16.56 | $46.3K | 127,771 |
| Aug 27, 2026 | Kalowski Lee | officer: CFO and President | Sell | 3,972 | $16.56 | $65.8K | 138,471 |
| Feb 27, 2026 | Kalowski Lee | officer: CFO and President | Sell | 3,995 | $4.51 | $18.0K | 35,943 |
| Feb 27, 2026 | Morrison Jodie Pope | director, officer: CEO | Sell | 9,896 | $4.51 | $44.7K | 89,104 |
| Feb 27, 2026 | Violette Shelia M. | officer: Chief Scientific Officer | Sell | 2,815 | $4.51 | $12.7K | 55,569 |
| Aug 26, 2025 | Violette Shelia M. | Chief Scientific Officer | Sell | 2,990 | $1.80 | $5.4K | 0 |
| Aug 14, 2024 | TZIANABOS ARTHUR | Sell | 265 | $24.20 | $6.4K | 7,983 | |
| Apr 23, 2024 | Alloway Paul | See Remarks | Sell | 268 | $24.21 | $6.5K | 2,596 |
| Apr 23, 2024 | Michaud Charles Jr | See Remarks | Sell | 75 | $24.20 | $1.8K | 927 |
| Feb 15, 2024 | TZIANABOS ARTHUR | Sell | 13,037 | $0.57 | $7.4K | 128,778 | |
| Jan 5, 2024 | Alloway Paul | See Remarks | Sell | 7,280 | $0.57 | $4.1K | 28,036 |
| Jan 5, 2024 | Michaud Charles Jr | See Remarks | Sell | 1,708 | $0.57 | $975.27 | 11,598 |
| Sep 8, 2023 | Seymour Albert | See Remarks | Sell | 1,448 | $1.15 | $1.7K | 150,874 |
| Aug 7, 2023 | Jordan Julie | Chief Medical Officer | Sell | 1,853 | $1.39 | $2.6K | 7,496 |
| Aug 4, 2023 | Jordan Julie | Chief Medical Officer | Sell | 99 | $1.31 | $129.69 | 2,770 |
| Mar 6, 2023 | Alloway Paul | See Remarks | Sell | 10,965 | $1.45 | $15.9K | 16,706-40% |
| Jan 11, 2023 | Alloway Paul | See Remarks | Sell | 3,090 | $1.39 | $4.3K | 20,103 |
| Jan 11, 2023 | Blum Michael Lee | Chief Commercial Officer | Sell | 2,454 | $1.39 | $3.4K | 13,538 |
| Jan 11, 2023 | Seymour Albert | See Remarks | Sell | 3,620 | $1.39 | $5.0K | 143,166 |
| Jan 11, 2023 | Smith W Bradford | See Remarks | Sell | 3,729 | $1.39 | $5.2K | 14,219 |
| Jan 11, 2023 | TZIANABOS ARTHUR | Director | Sell | 10,616 | $1.39 | $14.8K | 108,395 |
| Jan 12, 2022 | Cohn Gabriel | Chief Medical Officer | Sell | 1,661 | $3.78 | $6.3K | 2,629-39% |
| Jan 12, 2022 | Kelly Timothy P | Chief Operating Officer | Sell | 1,406 | $3.78 | $5.3K | 2,224-39% |
| Jan 12, 2022 | Seymour Albert | Chief Scientific Officer | Sell | 1,661 | $3.78 | $6.3K | 131,646 |
| Jan 12, 2022 | Smith W Bradford | CFO & Treasurer | Sell | 2,182 | $3.78 | $8.2K | 4,418-33% |
| Jan 12, 2022 | TZIANABOS ARTHUR | President & CEO | Sell | 5,354 | $3.78 | $20.2K | 86,011 |
| Sep 8, 2021 | Kelly Timothy P | See Remarks. | Sell | 54 | $7.70 | $415.80 | 0Exit |
| Mar 3, 2021 | Kelly Timothy P | See Remarks. | Sell | 6,232 | $11.16 | $69.6K | 0Exit |
QTTB Insiders
Similar Stocks to QTTB
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B